版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、mTOR信號(hào)轉(zhuǎn)導(dǎo)與腎臟損傷,,The structure and discovery of rapamycin,Rapamycins are macrocyclic lactones that possess immunosuppressive, antifungal and antitumor properties,Rapa Nui,Structure,The key events for rapamycin,1970 Rapamyc
2、in-producing Streptomyces hygroscopicus taken from Rapa Nui1975 Purification of rapamycin and identification of fungicidal activity 1977 Immunosuppressive activity discovered1984 Antitumour activity discovered 1995 I
3、dentification of the target of rapamycin in mammalian (mTOR)1999 Approved by US FDA for use in preventing host-rejection2003 Approved by FDA for use in drug-eluting stents2007 Approved by FDA for treatment of renal-ce
4、ll carcinoma2008 Approved by FDA for treatment of mantle cell lymphoma2010 Approved by FDA for treatment of tuberous sclerosis2011 Approved by FDA for treatment of pancreatic cancer2013 Crystal structure of mTOR disc
5、overed,,,The structure and composition of mTOR complex,,Annu Rev Immunol. 2012 ; 30: 39–68.,mTOR is a serine/threonine kinase with homology to PI3' kinase,Composition,Structure,,,Upstream mTOR signaling,Annu Rev Immu
6、nol. 2012 ; 30: 39–68.,,,,,Downstream processes of mTOR signaling,Modified from Nature: 493:338-45,The impact of mTOR on disease,Renal cancerPKDKidney transplantationPodocytopathyDNAKI, et al,,Rictor/mTORC2 in tubul
7、ar cell survival and AKIRheb/mTORC1 in fibroblast activation and kidney fibrosisRictor/Mtorc2 in fibroblast activation and kidney fibrosis,Activation of mTORC2 signaling in NRK-52E cells after cisplatin treatment,Knock
8、ing down Rictor inhibits mTORC2 signaling in NRK-52E cells after cisplatin treatment,Down regulating Rictor expression aggravates cisplatin-induced tubular cell apoptosis,Down regulating Rictor expression inhibits tubula
9、r cell autophagy after cisplatin treatment,Metformin inhibits cell apoptosis aggravated by Rictor downregulation in the presence of cisplatin,Creating the mice with tubular cell specific deletion of Rictor,Mice with tubu
10、lar cell specific deletion of Rictor are susceptible to cisplatin-induced AKI,More tubular cell apoptosis is found in tubular-Rictor -/- mice after cisplatin injection,Autophagy is inhibited in tubular cells from the kno
11、ckouts after cisplatin injection,Summary (1),Rictor/mTORC2 protects against cisplatin-induced tubular cell death and AKI.,,Origins and activation of myofibroblast in the kidney,mTORC1mTORC2,?,Rictor/mTORC2 in tubular ce
12、ll survival and AKIRheb/mTORC1 in fibroblast activation and kidney fibrosisRictor/Mtorc2 in fibroblast activation and kidney fibrosis,Activation of Rheb/mTORC1 signaling in interstitial cells from the fibrotic kidneys,
13、Activation of Rheb/mTORC1 signaling in myofibroblasts from the fibrotic kidneys,TGF-β1 promotes Rheb activation and expression in NRK-49F Cells,TGF-β1 promotes mTORC1 signaling activation in NRK-49F Cells,Knocking down R
14、heb inhibits mTORC1 signaling and fibroblast activation induced by TGF-β1,Rapamycin blocks mTORC1 signaling and fibroblast activation induced by TGF-β1,Ectopic expression of Rheb promotes mTORC1 signaling and fibroblast
15、activation,Ectopic Rheb expression induces kidney interstitial fibrosis in mice,Rapamycin ameliorates kidney fibrosis in Rheb transgenics,Speci?c deletion of TSC1 in ?broblasts in mice,Speci?c deletion of TSC1 in ?brobla
16、sts induces focal kidney interstitial fibrosis in mice,Rapamycin ameliorates kidney ?brosis in Fibroblast-Tsc1-/- mice,Summary (2),TSC/Rheb/mTORC1 signaling activation promotes fibroblast activation and kidney interstiti
17、al ?brosis.,Rictor/mTORC2 in tubular cell survival and AKIRheb/mTORC1 in fibroblast activation and kidney fibrosisRictor/mTORC2 in fibroblast activation and kidney fibrosis,Activation of mTORC2 signaling in the fibrob
18、lasts from the fibrotic kidneys,Knocking down Rictor expression blocks TGFβ1-induced NRK-49F cell activation,Creating mice with Specific deletion of Rictor in ?broblast,Specific deletion of Rictor in ?broblast ameliorate
19、s UUO nephropathy in mice,Summary (3),Rictor/mTORC2 regulates ?broblast activation and kidney fibrosis in mice with UUO nephropathy.,Conclusion,Rictor/MtorC2 protects against cisplatin-induced tubular cell apoptos
20、is and AKI; Both TSC/Rheb/mTORC1 and Rictor/mTORC2 signalings play important roles in promoting fibroblast activation and kidney fibrosis.,致謝,科技部973項(xiàng)目(2012CB51761)國(guó)家自然科學(xué)基金(面上項(xiàng)目, 81070550 )江蘇省特聘教授計(jì)劃啟動(dòng)經(jīng)費(fèi),
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- mTOR信號(hào)轉(zhuǎn)導(dǎo)通路與亞砷酸反應(yīng)關(guān)聯(lián)的研究.pdf
- 細(xì)胞通訊與信號(hào)轉(zhuǎn)導(dǎo)
- ATP通過(guò)激活A(yù)kt-mTOR-STAT3信號(hào)轉(zhuǎn)導(dǎo)通路促進(jìn)脊髓損傷修復(fù).pdf
- 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)與疾病
- 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)與疾病
- 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)
- 《信號(hào)轉(zhuǎn)導(dǎo)與腫瘤》ppt課件
- 硫辛酸抑制2型糖尿病大鼠腎臟氧化應(yīng)激及mTOR信號(hào)轉(zhuǎn)導(dǎo)通路激活.pdf
- 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)異常與疾病
- 細(xì)胞凋亡及其信號(hào)轉(zhuǎn)導(dǎo)
- 細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)基礎(chǔ)
- 利用DNA拓?fù)浣Y(jié)構(gòu)探針研究DNA損傷信號(hào)轉(zhuǎn)導(dǎo).pdf
- 十細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)異常與疾病
- 赤霉素信號(hào)轉(zhuǎn)導(dǎo)與植物的矮化
- 研信號(hào)轉(zhuǎn)導(dǎo)與疾病醫(yī)學(xué)醫(yī)藥
- 細(xì)胞的信號(hào)轉(zhuǎn)導(dǎo)和整合
- 內(nèi)皮細(xì)胞損傷及增殖信號(hào)轉(zhuǎn)導(dǎo)通路的研究.pdf
- 運(yùn)動(dòng)對(duì)大鼠骨骼PI3K-AKt-mTor與MAPK信號(hào)轉(zhuǎn)導(dǎo)途徑的影響.pdf
- mTOR-MAPK信號(hào)轉(zhuǎn)導(dǎo)途徑對(duì)細(xì)胞倍體化的作用及修飾機(jī)制.pdf
- 信號(hào)轉(zhuǎn)導(dǎo)通路與組織器官纖維化
評(píng)論
0/150
提交評(píng)論